Novo launches Wegovy weight-loss pill for sale in US

By Jacob Gronholt-Pedersen and Bhanvi Satija COPENHAGEN/LONDON, Jan 5 (Reuters) - Danish drugmaker Novo Nordisk is launching its once-daily Wegovy pill in the United States on Monday, offering 1.5 milligram (mg) and 4 mg doses at $149 per month for self-paying patients in an intensely competitive weight-loss drug market. The pill was approved by the U.S. Food and Drug Administration last month,